Health Economics, Policy and Law

2006 - 2025

From Cambridge University Press
Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 6, issue 4, 2011

Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE pp. 435-447

Rachel Baker, Sue Chilton, Cam Donaldson, Michael Jones-Lee, Emily Lancsar, Helen Mason, Hugh Metcalf, Mark Pennington and John Wildman

Social preferences for the inclusion of indirect benefits in the evaluation of publicly funded health services: results from an Australian survey pp. 449-468

John McKie and Jeff Richardson

Health technology appraisal and the courts: accountability for reasonableness and the judicial model of procedural justice pp. 469-488

Keith Syrett

Estimating the cost of smoking to the NHS in England and the impact of declining prevalence pp. 489-508

Christine Callum, Seán Boyle and Amanda Sandford

Breaking up is hard to do: the economic impact of provisional funding contingent upon evidence development pp. 509-527

Duncan Mortimer, Jing Jing Li, Jennifer Watts and Anthony Harris

Dying of corruption pp. 529-547

Sören Holmberg and Bo Rothstein

Choice and privatisation in Swedish primary care pp. 549-569

Anders Anell

Volume 6, issue 3, 2011

Information-oriented patients and physician career satisfaction: is there a link? pp. 295-311

Hai Fang and John Rizzo

Getting out what we put in: productivity of the English National Health Service pp. 313-335

Adriana Castelli, Mauro Laudicella, Andrew Street and Padraic Ward

Determinants of branded prescription medicine prices in OECD countries pp. 337-367

Panos G. Kanavos and Sotiris Vandoros

The generic drug market in Japan: will it finally take off? pp. 369-389

Toshiaki Iizuka and Kensuke Kubo

Should health authorities offer risk-sharing contracts to pharmaceutical firms? A theoretical approach pp. 391-403

Fernando Antonanzas, Carmelo Juarez-Castello and Roberto Rodriguez-Ibeas

A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory study pp. 405-433

Emmanouil Mentzakis, Patricia Stefanowska and Jeremiah Hurley

Volume 6, issue 2, 2011

Pay scheme preferences and health policy objectives pp. 157-173

Birgit Abelsen

On the socio-economic determinants of antenatal care utilization in Azerbaijan: evidence and policy implications for reforms pp. 175-203

Nazim N. Habibov

Equity in health care: the Irish perspective pp. 205-217

Samantha Smith and Charles Normand

Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system pp. 219-235

Lieke H. H. M. Boonen and Frederik T. Schut

Cooperation and conflict between very similar occupations: the case of anesthesia pp. 237-264

David Kalist, Noelle A. Molinari and Stephen Spurr

Tobacco: a product like any other? pp. 265-272

Kirill Danishevskiy and Martin McKee

Commentary 1: the ethics of licensing smokers pp. 273-277

T. M. Wilkinson

Commentary 2: criminalising the supply of tobacco pp. 279-281

Emily Jackson

Response pp. 283-285

Kirill Danishevskiy and Martin McKee

Volume 6, issue 1, 2011

New Zealand’s Primary Health Care Strategy: early effects of the new financing and payment system for general practice and future challenges pp. 1-21

Jacqueline Cumming and Nicholas Mays

Changes in the inequality of mental health: suicide in Australia, 1907–2003 pp. 23-42

Darrel P. Doessel, Ruth Williams and Jennie R. Robertson

Eliminating drug price differentials across government programmes in the USA pp. 43-64

Kalipso Chalkidou, Gerard F Anderson and Ruth Faden

European policymaking on the tobacco advertising ban: the importance of escape routes pp. 65-84

Sandra Adamini, Esther Versluis and Hans Maarse

Evolution of Taiwan’s health care system pp. 85-107

Jui-Fen Rachel Lu and Tung-Liang Chiang

Effects of purchaser competition in the Dutch health system: is the glass half full or half empty? pp. 109-123

Frederik T. Schut and Wynand P. M. M. van de Ven

The politics of health-care reform in the Netherlands since 2006 pp. 125-134

Hans Maarse and Aggie Paulus

Managed competition in the Dutch health system: is there a realistic alternative? pp. 135-137

Frederik T. Schut and Wynand P. M. M. van de Ven

The practice of markets in Dutch health care: are we drinking from the same glass? pp. 139-145

Roland Bal and Teun Zuiderent-Jerak

Volume 5, issue 4, 2010

Optimising waiting: a view from the English National Health Service pp. 397-409

Anthony J. Harrison and John Appleby

Understanding recent increases in chronic disease treatment rates: more disease or more detection? pp. 411-435

David H. Howard, Kenneth E. Thorpe and Susan H. Busch

What factors influence seniors’ desire for choice among health insurance options? Survey results on the Medicare prescription drug benefit pp. 437-457

Thomas Rice, Yaniv Hanoch and Janet Cummings

Hospital prices and market structure in the hospital and insurance industries pp. 459-479

Asako S. Moriya, William Vogt and Martin Gaynor

The introduction of a targeted user-pays approach to funding high-level residential aged care in Australia: an empirical investigation of the impact on price pp. 481-508

Susan Gargett

Money or mental health: the cost of alleviating psychological distress with monetary compensation versus psychological therapy pp. 509-516

Christopher J. Boyce and Alex M. Wood

Volume 5, issue 3, 2010

Are health problems systemic? Politics of access and choice under Beveridge and Bismarck systems pp. 269-293

Zeynep Or, Chantal Cases, Melanie Lisac, Karsten Vrangbæk, Ulrika Winblad and Gwyn Bevan

The experience of implementing choice at point of referral: a comparison of the Netherlands and England pp. 295-317

Anna Dixon, Ruth Robertson and Roland Bal

Is Canada odd? A comparison of European and Canadian approaches to choice and regulation of the public/private divide in health care pp. 319-341

Colleen M. Flood and Amanda Haugan

Choice of providers and mutual healthcare purchasers: can the English National Health Service learn from the Dutch reforms?1 pp. 343-363

Gwyn Bevan and Wynand P. M. M. van de Ven

Choice cuts: parsing policymakers’ pursuit of patient empowerment from an individual perspective pp. 365-387

Mark Schlesinger

Volume 5, issue 2, 2010

Equity in Irish health care financing: measurement issues pp. 149-169

Samantha Smith

Neo-liberal economic practices and population health: a cross-national analysis, 1980–2004 pp. 171-199

Melissa Tracy, Margaret E. Kruk, Christine Harper and Sandro Galea

Individual responsibility for what? – A conceptual framework for exploring the suitability of private financing in a publicly funded health-care system pp. 201-223

Gustav Tinghög, Per Carlsson and Carl Hampus Lyttkens

Co-payments in the NHS: an analysis of the normative arguments pp. 225-246

Albert Weale and Sarah Clark

Letter pp. 247-247

Andrew Street

Response pp. 249-250

Julian Le Grand

Volume 5, issue 1, 2010

User choice in European health systems: towards a systematic framework for analysis pp. 13-30

Florian P. Kreisz and Christian Gericke

Access and choice – competition under the roof of solidarity in German health care: an analysis of health policy reforms since 2004 pp. 31-52

Melanie Lisac, Lutz Reimers, Klaus-Dirk Henke and Sophia Schlette

Does competition among general practitioners increase or decrease the consumption of specialist health care? pp. 53-70

Trond Tjerbo

The ten characteristics of the high-performing chronic care system pp. 71-90

Chris Ham

Contingent valuation: what needs to be done? pp. 91-111

Richard D. Smith and Tracey H. Sach